Search results - 6 results

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

were living with a diagnosed viraemic infection. In 2020, an estimated 641 000 (623 000-765 000) patients initiated treatment. INTERPRETATION: At the beginning of 2020, there were an estimated 56·8 ...

Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method

the same time period we also obtained pseudo-anonymized identifier information from treatment and harm reduction service providers. We estimated the total number of PWID in Brussels using ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

all chronically infected HCV patients a more timely access to treatment. Health Topics:  Hepatitis A, B, C, D and E Hépatites A, B, C, D et E Hepatitis A, B, C, D en E Service:  Maladies virales Virale ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

determinations before implementation of new treatment strategies. This baseline characterization of the circulating genotypes is indispensable for a continuous surveillance, especially for the investigation of the ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

analysis is the result of a descriptive crosssectional study, based on data extracted from the linkage between a database of people in treatment for substance use disorders in Belgium and a database of the ...

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method

capture-recapture harm reduction hidden population multiplier method People who inject drugs treatment Abstract: Background For Belgium, available estimates of the number of people who inject drugs (PWID) are based ...

QR code

QR code for this page URL